Birchview Capital as of March 31, 2020
Portfolio Holdings for Birchview Capital
Birchview Capital holds 46 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bristol Myers Squibb (BMY) | 38.9 | $44M | 786k | 55.74 | |
Accelr8 Technology | 16.2 | $18M | 2.2M | 8.33 | |
Neurocrine Biosciences (NBIX) | 5.7 | $6.4M | 74k | 86.55 | |
Quidel Corporation | 4.2 | $4.8M | 49k | 97.80 | |
ACADIA Pharmaceuticals (ACAD) | 3.4 | $3.9M | 92k | 42.25 | |
Biogen Idec (BIIB) | 3.1 | $3.5M | 11k | 316.36 | |
Karyopharm Therapeutics (KPTI) | 2.5 | $2.8M | 148k | 19.21 | |
Rts/bristol-myers Squibb Compa | 2.4 | $2.7M | 707k | 3.80 | |
Vermillion | 2.4 | $2.7M | 3.2M | 0.83 | |
United Therapeutics Corporation (UTHR) | 1.5 | $1.7M | 18k | 94.83 | |
Acceleron Pharma | 1.5 | $1.7M | 19k | 89.87 | |
Oxford Immunotec Global | 1.4 | $1.6M | 170k | 9.26 | |
Gilead Sciences (GILD) | 1.3 | $1.5M | 20k | 74.75 | |
Contrafect | 1.3 | $1.5M | 256k | 5.76 | |
Masimo Corporation (MASI) | 1.3 | $1.4M | 8.0k | 177.12 | |
Chemocentryx | 1.1 | $1.2M | 30k | 40.17 | |
Epizyme | 0.8 | $931k | 60k | 15.52 | |
Arena Pharmaceuticals | 0.8 | $924k | 22k | 42.00 | |
Vanda Pharmaceuticals (VNDA) | 0.7 | $829k | 80k | 10.36 | |
Albireo Pharma | 0.7 | $786k | 48k | 16.38 | |
Amarin Corporation (AMRN) | 0.6 | $720k | 180k | 4.00 | |
Harrow Health (HROW) | 0.6 | $688k | 180k | 3.82 | |
ImmunoGen | 0.6 | $648k | 190k | 3.41 | |
Eqt Midstream Partners | 0.5 | $605k | 51k | 11.80 | |
Arvinas Ord (ARVN) | 0.5 | $604k | 15k | 40.27 | |
Corcept Therapeutics Incorporated (CORT) | 0.5 | $594k | 50k | 11.88 | |
Odonate Therapeutics Ord | 0.5 | $552k | 20k | 27.60 | |
Intercept Pharmaceuticals In | 0.5 | $523k | 8.3k | 63.01 | |
Soleno Therapeutics | 0.4 | $480k | 202k | 2.38 | |
Stoke Therapeutics (STOK) | 0.4 | $458k | 20k | 22.90 | |
G1 Therapeutics (GTHX) | 0.4 | $441k | 40k | 11.03 | |
Inflarx Nv (IFRX) | 0.4 | $420k | 110k | 3.82 | |
Xencor (XNCR) | 0.3 | $368k | 12k | 29.92 | |
Amicus Therapeutics (FOLD) | 0.3 | $351k | 38k | 9.24 | |
Biohaven Pharmaceutical Holding | 0.3 | $340k | 10k | 34.00 | |
Progyny (PGNY) | 0.3 | $318k | 15k | 21.20 | |
Translate Bio | 0.3 | $299k | 30k | 9.97 | |
Voyager Therapeutics (VYGR) | 0.2 | $274k | 30k | 9.13 | |
Pioneer Natural Resources (PXD) | 0.2 | $267k | 3.8k | 70.26 | |
Kalvista Pharmaceuticals (KALV) | 0.2 | $230k | 30k | 7.67 | |
Apellis Pharmaceuticals (APLS) | 0.2 | $214k | 8.0k | 26.75 | |
Dicerna Pharmaceuticals | 0.2 | $184k | 10k | 18.40 | |
Tg Therapeutics (TGTX) | 0.1 | $148k | 15k | 9.87 | |
Yield10 Bioscience | 0.1 | $71k | 19k | 3.75 | |
Workhorse Group Inc ordinary shares (WKHS) | 0.0 | $45k | 25k | 1.80 | |
BioCryst Pharmaceuticals (BCRX) | 0.0 | $40k | 20k | 2.00 |